Literature DB >> 925611

Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.

S W Russell, W F Doe, A T McIntosh.   

Abstract

The state in which macrophages (Mphi) from regressing Moloney sarcomas could kill tumor target cells was a highly labile one which decayed rapidly in vitro. Thereafter, regressor Mphi were noncytolytic. Mphi from several different progressing sarcomas failed to kill, even when challenged with target cells immediately after explantation. Similarly, thioglycollate-induced peritoneal Mphi (TG-Mphi) did not kill. Noncytolygic Mphi derived either from progressing sarcomas or from long-term (up to 96 h) cultures of regressor Mphi were exquisitely sensitive to stimulation by bacterial lipopolysaccharide (LPS); picogram/milliliter amounts induced killing. Similar concentrations of LPS had no demonstrable effect on TG-Mphi. Thus, tumor Mphi generally appeared to have been primed in vivo, with those in regressing sarcomas having additionally acquired cytolytic activity. Inability of progressor Mphi to kill apparently stemmed from lack of, or failure to respond to, the signal needed in vivo to trigger cytolytic activity, rather than the total absence of activation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925611      PMCID: PMC2181899          DOI: 10.1084/jem.146.6.1511

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Estimation of 3-deoxy sugars by means of the malonaldehyde-thiobarbituric acid reaction.

Authors:  M A CYNKIN; G ASHWELL
Journal:  Nature       Date:  1960-04-09       Impact factor: 49.962

2.  Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

Authors:  W F Piessens; W H Churchill
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid.

Authors:  H A Chapman; J B Hibbs
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

4.  Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas.

Authors:  S W Russell; G Y Gillespie; A T McIntosh
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

5.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

6.  Macrophages and the tumour bearing host.

Authors:  R Evans
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  Endotoxin and double stranded RNA render macrophages cytotoxic.

Authors:  P Alexander; R Evans
Journal:  Nat New Biol       Date:  1971-07-21

8.  Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.

Authors:  G Y Gillespie; C B Hansen; R G Hoskins; S W Russell
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

9.  Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression.

Authors:  S W Russell; G Y Gillespie; C B Hansen; C G Cochrane
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

10.  Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells.

Authors:  S W Russell; W F Doe; R G Hoskins; C G Cochrane
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

View more
  28 in total

1.  Subpopulations of mononuclear leukocytes associated with inhibition of Ehrlich ascites tumor growth by treatment with Bothrops jararaca venom.

Authors:  Mariana Morena de Vieira Santos; Reinaldo José da Silva; Márcia Guimarães da Silva; Denise Fecchio
Journal:  Mediators Inflamm       Date:  2004-02       Impact factor: 4.711

Review 2.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

3.  The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.

Authors:  R J North
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 4.  Modulation of antitumor immunity--immunobiologic approaches.

Authors:  R J North; E S Dye; C D Mills; J P Chandler
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Oligoesculin fraction induces anti-tumor effects and promotes immune responses on B16-F10 mice melanoma.

Authors:  Imen Mokdad Bzeouich; Nadia Mustapha; Aicha Sassi; Kamel Ghedira; Mohamed Ghoul; Latifa Chebil; José Luis; Leila Chekir-Ghedira
Journal:  Tumour Biol       Date:  2016-03-10

Review 7.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

8.  Differential functional genomic effects of anti-inflammatory phytocompounds on immune signaling.

Authors:  Shao-Chih Chiu; Shan-Wen Tsao; Pei-Ing Hwang; Staniforth Vanisree; Yi-An Chen; Ning-Sun Yang
Journal:  BMC Genomics       Date:  2010-09-24       Impact factor: 3.969

9.  Development of functional diversity in mouse macrophages. Mutual exclusion of two phenotypic states.

Authors:  D J Laszlo; P M Henson; L K Remigio; L Weinstein; C Sable; P W Noble; D W Riches
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

10.  The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.

Authors:  G Poste
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.